Northeastern University: New Antibody Treatment Could Help High Risk Patients Recover From COVID-19
November 11, 2020
November 11, 2020
BOSTON, Massachusetts, Nov. 11 -- Northeastern University issued the following news:
A newly approved antibody therapy for COVID-19, produced by the pharmaceutical firm Eli Lilly and Company, could help high-risk patients recover from the disease as long as the virus is detected soon after infection, says Mansoor Amiji, university distinguished professor of pharmaceutical sciences and chemical engineering at Northeastern.
The Food and Drug Administration on Tuesday app . . .
A newly approved antibody therapy for COVID-19, produced by the pharmaceutical firm Eli Lilly and Company, could help high-risk patients recover from the disease as long as the virus is detected soon after infection, says Mansoor Amiji, university distinguished professor of pharmaceutical sciences and chemical engineering at Northeastern.
The Food and Drug Administration on Tuesday app . . .